nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—CYP2C9—brain cancer	0.533	1	CbGaD
Propafenone—CYP2D6—Lomustine—brain cancer	0.061	0.192	CbGbCtD
Propafenone—CYP1A2—Carmustine—brain cancer	0.0604	0.19	CbGbCtD
Propafenone—CYP2D6—Hydroxyurea—brain cancer	0.0463	0.145	CbGbCtD
Propafenone—CYP3A4—Temozolomide—brain cancer	0.0456	0.143	CbGbCtD
Propafenone—CYP3A4—Lomustine—brain cancer	0.0388	0.122	CbGbCtD
Propafenone—CYP2C8—Etoposide—brain cancer	0.0231	0.0727	CbGbCtD
Propafenone—CYP1A2—Etoposide—brain cancer	0.0179	0.0563	CbGbCtD
Propafenone—ABCB1—Etoposide—brain cancer	0.0157	0.0492	CbGbCtD
Propafenone—CYP3A4—Etoposide—brain cancer	0.00938	0.0295	CbGbCtD
Propafenone—KCNH2—Hematopoietic Stem Cell Differentiation—FLI1—brain cancer	0.00117	0.0667	CbGpPWpGaD
Propafenone—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.00106	0.0605	CbGpPWpGaD
Propafenone—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000954	0.0543	CbGpPWpGaD
Propafenone—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000868	0.0494	CbGpPWpGaD
Propafenone—Oxaprozin—CYP2C9—brain cancer	0.000825	0.358	CrCbGaD
Propafenone—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00074	0.0421	CbGpPWpGaD
Propafenone—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000664	0.0378	CbGpPWpGaD
Propafenone—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000607	0.0346	CbGpPWpGaD
Propafenone—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000604	0.0344	CbGpPWpGaD
Propafenone—Carvedilol—VEGFA—brain cancer	0.000597	0.259	CrCbGaD
Propafenone—Carvedilol—CYP2C9—brain cancer	0.000459	0.199	CrCbGaD
Propafenone—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000458	0.0261	CbGpPWpGaD
Propafenone—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.000441	0.0251	CbGpPWpGaD
Propafenone—Dextropropoxyphene—CYP2C9—brain cancer	0.000422	0.183	CrCbGaD
Propafenone—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000376	0.0214	CbGpPWpGaD
Propafenone—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000362	0.0206	CbGpPWpGaD
Propafenone—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000319	0.0182	CbGpPWpGaD
Propafenone—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000307	0.0175	CbGpPWpGaD
Propafenone—KCNH2—Hematopoietic Stem Cell Differentiation—VAV1—brain cancer	0.000281	0.016	CbGpPWpGaD
Propafenone—ABCB1—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000274	0.0156	CbGpPWpGaD
Propafenone—Infestation—Temozolomide—brain cancer	0.000267	0.00207	CcSEcCtD
Propafenone—Depression—Temozolomide—brain cancer	0.000266	0.00207	CcSEcCtD
Propafenone—Cardiac arrest—Etoposide—brain cancer	0.000263	0.00205	CcSEcCtD
Propafenone—Nausea—Lomustine—brain cancer	0.000263	0.00205	CcSEcCtD
Propafenone—Hypotension—Procarbazine—brain cancer	0.000263	0.00204	CcSEcCtD
Propafenone—Neuropathy peripheral—Temozolomide—brain cancer	0.000262	0.00203	CcSEcCtD
Propafenone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000261	0.0149	CbGpPWpGaD
Propafenone—Stomatitis—Temozolomide—brain cancer	0.00026	0.00202	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000256	0.00199	CcSEcCtD
Propafenone—Insomnia—Procarbazine—brain cancer	0.000255	0.00198	CcSEcCtD
Propafenone—SCN5A—SIDS Susceptibility Pathways—HES5—brain cancer	0.000254	0.0145	CbGpPWpGaD
Propafenone—Paraesthesia—Procarbazine—brain cancer	0.000253	0.00196	CcSEcCtD
Propafenone—Hepatobiliary disease—Temozolomide—brain cancer	0.000252	0.00196	CcSEcCtD
Propafenone—Somnolence—Procarbazine—brain cancer	0.00025	0.00194	CcSEcCtD
Propafenone—Cramp muscle—Etoposide—brain cancer	0.000249	0.00194	CcSEcCtD
Propafenone—Haemoglobin—Carmustine—brain cancer	0.000249	0.00194	CcSEcCtD
Propafenone—Haemorrhage—Carmustine—brain cancer	0.000248	0.00193	CcSEcCtD
Propafenone—Ill-defined disorder—Hydroxyurea—brain cancer	0.000248	0.00192	CcSEcCtD
Propafenone—Anaemia—Hydroxyurea—brain cancer	0.000247	0.00192	CcSEcCtD
Propafenone—Hypoaesthesia—Carmustine—brain cancer	0.000247	0.00192	CcSEcCtD
Propafenone—KCNH2—SIDS Susceptibility Pathways—HES5—brain cancer	0.000246	0.014	CbGpPWpGaD
Propafenone—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000246	0.014	CbGpPWpGaD
Propafenone—Decreased appetite—Procarbazine—brain cancer	0.000245	0.0019	CcSEcCtD
Propafenone—Alanine aminotransferase increased—Etoposide—brain cancer	0.000244	0.0019	CcSEcCtD
Propafenone—Connective tissue disorder—Carmustine—brain cancer	0.000244	0.00189	CcSEcCtD
Propafenone—Fatigue—Procarbazine—brain cancer	0.000243	0.00189	CcSEcCtD
Propafenone—Haemoglobin—Temozolomide—brain cancer	0.000241	0.00187	CcSEcCtD
Propafenone—Malaise—Hydroxyurea—brain cancer	0.000241	0.00187	CcSEcCtD
Propafenone—Pain—Procarbazine—brain cancer	0.000241	0.00187	CcSEcCtD
Propafenone—Constipation—Procarbazine—brain cancer	0.000241	0.00187	CcSEcCtD
Propafenone—Hepatitis—Temozolomide—brain cancer	0.00024	0.00186	CcSEcCtD
Propafenone—Haemorrhage—Temozolomide—brain cancer	0.00024	0.00186	CcSEcCtD
Propafenone—Dysphagia—Etoposide—brain cancer	0.000239	0.00186	CcSEcCtD
Propafenone—Leukopenia—Hydroxyurea—brain cancer	0.000239	0.00186	CcSEcCtD
Propafenone—Visual impairment—Carmustine—brain cancer	0.000239	0.00186	CcSEcCtD
Propafenone—Hypoaesthesia—Temozolomide—brain cancer	0.000238	0.00185	CcSEcCtD
Propafenone—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000237	0.0135	CbGpPWpGaD
Propafenone—Urinary tract disorder—Temozolomide—brain cancer	0.000237	0.00184	CcSEcCtD
Propafenone—Connective tissue disorder—Temozolomide—brain cancer	0.000235	0.00183	CcSEcCtD
Propafenone—Urethral disorder—Temozolomide—brain cancer	0.000235	0.00182	CcSEcCtD
Propafenone—Sweating increased—Etoposide—brain cancer	0.000233	0.00181	CcSEcCtD
Propafenone—Feeling abnormal—Procarbazine—brain cancer	0.000232	0.0018	CcSEcCtD
Propafenone—Eye disorder—Carmustine—brain cancer	0.000232	0.0018	CcSEcCtD
Propafenone—Convulsion—Hydroxyurea—brain cancer	0.000231	0.0018	CcSEcCtD
Propafenone—Visual impairment—Temozolomide—brain cancer	0.000231	0.00179	CcSEcCtD
Propafenone—Gastrointestinal pain—Procarbazine—brain cancer	0.00023	0.00179	CcSEcCtD
Propafenone—Flushing—Carmustine—brain cancer	0.00023	0.00179	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000226	0.00175	CcSEcCtD
Propafenone—Discomfort—Hydroxyurea—brain cancer	0.000225	0.00174	CcSEcCtD
Propafenone—Eye disorder—Temozolomide—brain cancer	0.000224	0.00174	CcSEcCtD
Propafenone—Urticaria—Procarbazine—brain cancer	0.000224	0.00174	CcSEcCtD
Propafenone—Tinnitus—Temozolomide—brain cancer	0.000223	0.00173	CcSEcCtD
Propafenone—Body temperature increased—Procarbazine—brain cancer	0.000223	0.00173	CcSEcCtD
Propafenone—Abdominal pain—Procarbazine—brain cancer	0.000223	0.00173	CcSEcCtD
Propafenone—Flushing—Temozolomide—brain cancer	0.000222	0.00173	CcSEcCtD
Propafenone—Cardiac disorder—Temozolomide—brain cancer	0.000222	0.00173	CcSEcCtD
Propafenone—Arrhythmia—Carmustine—brain cancer	0.000221	0.00172	CcSEcCtD
Propafenone—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00022	0.0125	CbGpPWpGaD
Propafenone—Alopecia—Carmustine—brain cancer	0.000219	0.0017	CcSEcCtD
Propafenone—Oedema—Hydroxyurea—brain cancer	0.000218	0.00169	CcSEcCtD
Propafenone—Angiopathy—Temozolomide—brain cancer	0.000217	0.00169	CcSEcCtD
Propafenone—Mental disorder—Carmustine—brain cancer	0.000217	0.00169	CcSEcCtD
Propafenone—Infection—Hydroxyurea—brain cancer	0.000216	0.00168	CcSEcCtD
Propafenone—Immune system disorder—Temozolomide—brain cancer	0.000216	0.00168	CcSEcCtD
Propafenone—Mediastinal disorder—Temozolomide—brain cancer	0.000216	0.00168	CcSEcCtD
Propafenone—Erythema—Carmustine—brain cancer	0.000216	0.00168	CcSEcCtD
Propafenone—Malnutrition—Carmustine—brain cancer	0.000216	0.00168	CcSEcCtD
Propafenone—Nervous system disorder—Hydroxyurea—brain cancer	0.000214	0.00166	CcSEcCtD
Propafenone—Infestation—Etoposide—brain cancer	0.000214	0.00166	CcSEcCtD
Propafenone—Infestation NOS—Etoposide—brain cancer	0.000214	0.00166	CcSEcCtD
Propafenone—Thrombocytopenia—Hydroxyurea—brain cancer	0.000213	0.00166	CcSEcCtD
Propafenone—Alopecia—Temozolomide—brain cancer	0.000212	0.00164	CcSEcCtD
Propafenone—Skin disorder—Hydroxyurea—brain cancer	0.000212	0.00164	CcSEcCtD
Propafenone—Renal failure—Etoposide—brain cancer	0.00021	0.00163	CcSEcCtD
Propafenone—Mental disorder—Temozolomide—brain cancer	0.00021	0.00163	CcSEcCtD
Propafenone—Neuropathy peripheral—Etoposide—brain cancer	0.000209	0.00163	CcSEcCtD
Propafenone—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000209	0.0119	CbGpPWpGaD
Propafenone—Malnutrition—Temozolomide—brain cancer	0.000209	0.00162	CcSEcCtD
Propafenone—Erythema—Temozolomide—brain cancer	0.000209	0.00162	CcSEcCtD
Propafenone—Jaundice—Etoposide—brain cancer	0.000208	0.00162	CcSEcCtD
Propafenone—Stomatitis—Etoposide—brain cancer	0.000208	0.00162	CcSEcCtD
Propafenone—Anorexia—Hydroxyurea—brain cancer	0.000208	0.00161	CcSEcCtD
Propafenone—Hypersensitivity—Procarbazine—brain cancer	0.000207	0.00161	CcSEcCtD
Propafenone—Dysgeusia—Temozolomide—brain cancer	0.000204	0.00159	CcSEcCtD
Propafenone—Vision blurred—Carmustine—brain cancer	0.000203	0.00158	CcSEcCtD
Propafenone—Tremor—Carmustine—brain cancer	0.000202	0.00157	CcSEcCtD
Propafenone—Asthenia—Procarbazine—brain cancer	0.000202	0.00157	CcSEcCtD
Propafenone—Hepatobiliary disease—Etoposide—brain cancer	0.000202	0.00157	CcSEcCtD
Propafenone—Anaemia—Carmustine—brain cancer	0.000199	0.00155	CcSEcCtD
Propafenone—Agranulocytosis—Etoposide—brain cancer	0.000199	0.00155	CcSEcCtD
Propafenone—Pruritus—Procarbazine—brain cancer	0.000199	0.00155	CcSEcCtD
Propafenone—Vision blurred—Temozolomide—brain cancer	0.000197	0.00153	CcSEcCtD
Propafenone—Tremor—Temozolomide—brain cancer	0.000195	0.00152	CcSEcCtD
Propafenone—Dyspnoea—Hydroxyurea—brain cancer	0.000194	0.00151	CcSEcCtD
Propafenone—Somnolence—Hydroxyurea—brain cancer	0.000194	0.0015	CcSEcCtD
Propafenone—Ill-defined disorder—Temozolomide—brain cancer	0.000193	0.0015	CcSEcCtD
Propafenone—Leukopenia—Carmustine—brain cancer	0.000193	0.0015	CcSEcCtD
Propafenone—Anaemia—Temozolomide—brain cancer	0.000193	0.0015	CcSEcCtD
Propafenone—Diarrhoea—Procarbazine—brain cancer	0.000193	0.0015	CcSEcCtD
Propafenone—Dyspepsia—Hydroxyurea—brain cancer	0.000192	0.00149	CcSEcCtD
Propafenone—Hypoaesthesia—Etoposide—brain cancer	0.000191	0.00148	CcSEcCtD
Propafenone—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00019	0.0108	CbGpPWpGaD
Propafenone—SCN5A—Cardiac Progenitor Differentiation—PDGFRA—brain cancer	0.00019	0.0108	CbGpPWpGaD
Propafenone—Decreased appetite—Hydroxyurea—brain cancer	0.000189	0.00147	CcSEcCtD
Propafenone—Urinary tract disorder—Etoposide—brain cancer	0.000189	0.00147	CcSEcCtD
Propafenone—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000188	0.00146	CcSEcCtD
Propafenone—Malaise—Temozolomide—brain cancer	0.000188	0.00146	CcSEcCtD
Propafenone—Urethral disorder—Etoposide—brain cancer	0.000188	0.00146	CcSEcCtD
Propafenone—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000188	0.0107	CbGpPWpGaD
Propafenone—Fatigue—Hydroxyurea—brain cancer	0.000188	0.00146	CcSEcCtD
Propafenone—Vertigo—Temozolomide—brain cancer	0.000187	0.00146	CcSEcCtD
Propafenone—Convulsion—Carmustine—brain cancer	0.000187	0.00145	CcSEcCtD
Propafenone—Leukopenia—Temozolomide—brain cancer	0.000187	0.00145	CcSEcCtD
Propafenone—Hypertension—Carmustine—brain cancer	0.000186	0.00145	CcSEcCtD
Propafenone—Constipation—Hydroxyurea—brain cancer	0.000186	0.00145	CcSEcCtD
Propafenone—Pain—Hydroxyurea—brain cancer	0.000186	0.00145	CcSEcCtD
Propafenone—Dizziness—Procarbazine—brain cancer	0.000186	0.00145	CcSEcCtD
Propafenone—Palpitations—Temozolomide—brain cancer	0.000184	0.00143	CcSEcCtD
Propafenone—Myalgia—Carmustine—brain cancer	0.000184	0.00143	CcSEcCtD
Propafenone—Chest pain—Carmustine—brain cancer	0.000184	0.00143	CcSEcCtD
Propafenone—Anxiety—Carmustine—brain cancer	0.000183	0.00142	CcSEcCtD
Propafenone—Cough—Temozolomide—brain cancer	0.000182	0.00141	CcSEcCtD
Propafenone—Convulsion—Temozolomide—brain cancer	0.000181	0.0014	CcSEcCtD
Propafenone—Hypertension—Temozolomide—brain cancer	0.00018	0.0014	CcSEcCtD
Propafenone—Feeling abnormal—Hydroxyurea—brain cancer	0.00018	0.00139	CcSEcCtD
Propafenone—Eye disorder—Etoposide—brain cancer	0.000179	0.00139	CcSEcCtD
Propafenone—Vomiting—Procarbazine—brain cancer	0.000179	0.00139	CcSEcCtD
Propafenone—Cardiac disorder—Etoposide—brain cancer	0.000178	0.00138	CcSEcCtD
Propafenone—Flushing—Etoposide—brain cancer	0.000178	0.00138	CcSEcCtD
Propafenone—Confusional state—Carmustine—brain cancer	0.000178	0.00138	CcSEcCtD
Propafenone—Myalgia—Temozolomide—brain cancer	0.000178	0.00138	CcSEcCtD
Propafenone—Rash—Procarbazine—brain cancer	0.000177	0.00138	CcSEcCtD
Propafenone—Dermatitis—Procarbazine—brain cancer	0.000177	0.00138	CcSEcCtD
Propafenone—Anxiety—Temozolomide—brain cancer	0.000177	0.00137	CcSEcCtD
Propafenone—Headache—Procarbazine—brain cancer	0.000176	0.00137	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000176	0.00137	CcSEcCtD
Propafenone—Oedema—Carmustine—brain cancer	0.000176	0.00137	CcSEcCtD
Propafenone—Discomfort—Temozolomide—brain cancer	0.000175	0.00136	CcSEcCtD
Propafenone—Infection—Carmustine—brain cancer	0.000175	0.00136	CcSEcCtD
Propafenone—Angiopathy—Etoposide—brain cancer	0.000174	0.00135	CcSEcCtD
Propafenone—Dry mouth—Temozolomide—brain cancer	0.000174	0.00135	CcSEcCtD
Propafenone—Immune system disorder—Etoposide—brain cancer	0.000173	0.00134	CcSEcCtD
Propafenone—Mediastinal disorder—Etoposide—brain cancer	0.000173	0.00134	CcSEcCtD
Propafenone—Thrombocytopenia—Carmustine—brain cancer	0.000172	0.00134	CcSEcCtD
Propafenone—Body temperature increased—Hydroxyurea—brain cancer	0.000172	0.00134	CcSEcCtD
Propafenone—Tachycardia—Carmustine—brain cancer	0.000172	0.00134	CcSEcCtD
Propafenone—Confusional state—Temozolomide—brain cancer	0.000172	0.00133	CcSEcCtD
Propafenone—Oedema—Temozolomide—brain cancer	0.00017	0.00132	CcSEcCtD
Propafenone—Alopecia—Etoposide—brain cancer	0.000169	0.00132	CcSEcCtD
Propafenone—Infection—Temozolomide—brain cancer	0.000169	0.00131	CcSEcCtD
Propafenone—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000169	0.00962	CbGpPWpGaD
Propafenone—Anorexia—Carmustine—brain cancer	0.000168	0.0013	CcSEcCtD
Propafenone—Nausea—Procarbazine—brain cancer	0.000167	0.0013	CcSEcCtD
Propafenone—Nervous system disorder—Temozolomide—brain cancer	0.000167	0.0013	CcSEcCtD
Propafenone—Thrombocytopenia—Temozolomide—brain cancer	0.000167	0.00129	CcSEcCtD
Propafenone—Skin disorder—Temozolomide—brain cancer	0.000165	0.00128	CcSEcCtD
Propafenone—Hypotension—Carmustine—brain cancer	0.000165	0.00128	CcSEcCtD
Propafenone—Hyperhidrosis—Temozolomide—brain cancer	0.000165	0.00128	CcSEcCtD
Propafenone—Dysgeusia—Etoposide—brain cancer	0.000163	0.00127	CcSEcCtD
Propafenone—Anorexia—Temozolomide—brain cancer	0.000162	0.00126	CcSEcCtD
Propafenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000161	0.00916	CbGpPWpGaD
Propafenone—Hypersensitivity—Hydroxyurea—brain cancer	0.00016	0.00125	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Carmustine—brain cancer	0.00016	0.00125	CcSEcCtD
Propafenone—Muscle spasms—Etoposide—brain cancer	0.00016	0.00125	CcSEcCtD
Propafenone—Insomnia—Carmustine—brain cancer	0.000159	0.00124	CcSEcCtD
Propafenone—Paraesthesia—Carmustine—brain cancer	0.000158	0.00123	CcSEcCtD
Propafenone—Dyspnoea—Carmustine—brain cancer	0.000157	0.00122	CcSEcCtD
Propafenone—Somnolence—Carmustine—brain cancer	0.000157	0.00122	CcSEcCtD
Propafenone—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000156	0.0089	CbGpPWpGaD
Propafenone—Asthenia—Hydroxyurea—brain cancer	0.000156	0.00121	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000155	0.0012	CcSEcCtD
Propafenone—Ill-defined disorder—Etoposide—brain cancer	0.000155	0.0012	CcSEcCtD
Propafenone—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000154	0.00879	CbGpPWpGaD
Propafenone—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000154	0.00878	CbGpPWpGaD
Propafenone—Anaemia—Etoposide—brain cancer	0.000154	0.0012	CcSEcCtD
Propafenone—Insomnia—Temozolomide—brain cancer	0.000154	0.0012	CcSEcCtD
Propafenone—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000153	0.00872	CbGpPWpGaD
Propafenone—Decreased appetite—Carmustine—brain cancer	0.000153	0.00119	CcSEcCtD
Propafenone—Paraesthesia—Temozolomide—brain cancer	0.000153	0.00119	CcSEcCtD
Propafenone—Gastrointestinal disorder—Carmustine—brain cancer	0.000152	0.00118	CcSEcCtD
Propafenone—Dyspnoea—Temozolomide—brain cancer	0.000152	0.00118	CcSEcCtD
Propafenone—Somnolence—Temozolomide—brain cancer	0.000151	0.00118	CcSEcCtD
Propafenone—Pain—Carmustine—brain cancer	0.000151	0.00117	CcSEcCtD
Propafenone—Constipation—Carmustine—brain cancer	0.000151	0.00117	CcSEcCtD
Propafenone—Malaise—Etoposide—brain cancer	0.00015	0.00117	CcSEcCtD
Propafenone—Vertigo—Etoposide—brain cancer	0.00015	0.00116	CcSEcCtD
Propafenone—Dyspepsia—Temozolomide—brain cancer	0.00015	0.00116	CcSEcCtD
Propafenone—Leukopenia—Etoposide—brain cancer	0.000149	0.00116	CcSEcCtD
Propafenone—Diarrhoea—Hydroxyurea—brain cancer	0.000149	0.00116	CcSEcCtD
Propafenone—Decreased appetite—Temozolomide—brain cancer	0.000148	0.00115	CcSEcCtD
Propafenone—Gastrointestinal disorder—Temozolomide—brain cancer	0.000147	0.00114	CcSEcCtD
Propafenone—Fatigue—Temozolomide—brain cancer	0.000147	0.00114	CcSEcCtD
Propafenone—Loss of consciousness—Etoposide—brain cancer	0.000147	0.00114	CcSEcCtD
Propafenone—Cough—Etoposide—brain cancer	0.000146	0.00113	CcSEcCtD
Propafenone—Pain—Temozolomide—brain cancer	0.000146	0.00113	CcSEcCtD
Propafenone—Constipation—Temozolomide—brain cancer	0.000146	0.00113	CcSEcCtD
Propafenone—Feeling abnormal—Carmustine—brain cancer	0.000145	0.00113	CcSEcCtD
Propafenone—Convulsion—Etoposide—brain cancer	0.000145	0.00112	CcSEcCtD
Propafenone—Hypertension—Etoposide—brain cancer	0.000144	0.00112	CcSEcCtD
Propafenone—Dizziness—Hydroxyurea—brain cancer	0.000144	0.00112	CcSEcCtD
Propafenone—Gastrointestinal pain—Carmustine—brain cancer	0.000144	0.00112	CcSEcCtD
Propafenone—Chest pain—Etoposide—brain cancer	0.000142	0.0011	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000141	0.0011	CcSEcCtD
Propafenone—Discomfort—Etoposide—brain cancer	0.00014	0.00109	CcSEcCtD
Propafenone—Feeling abnormal—Temozolomide—brain cancer	0.00014	0.00109	CcSEcCtD
Propafenone—Abdominal pain—Carmustine—brain cancer	0.000139	0.00108	CcSEcCtD
Propafenone—Body temperature increased—Carmustine—brain cancer	0.000139	0.00108	CcSEcCtD
Propafenone—Gastrointestinal pain—Temozolomide—brain cancer	0.000139	0.00108	CcSEcCtD
Propafenone—Vomiting—Hydroxyurea—brain cancer	0.000139	0.00108	CcSEcCtD
Propafenone—Rash—Hydroxyurea—brain cancer	0.000137	0.00107	CcSEcCtD
Propafenone—Confusional state—Etoposide—brain cancer	0.000137	0.00107	CcSEcCtD
Propafenone—Dermatitis—Hydroxyurea—brain cancer	0.000137	0.00107	CcSEcCtD
Propafenone—Headache—Hydroxyurea—brain cancer	0.000136	0.00106	CcSEcCtD
Propafenone—Infection—Etoposide—brain cancer	0.000135	0.00105	CcSEcCtD
Propafenone—Urticaria—Temozolomide—brain cancer	0.000135	0.00105	CcSEcCtD
Propafenone—Body temperature increased—Temozolomide—brain cancer	0.000135	0.00105	CcSEcCtD
Propafenone—Abdominal pain—Temozolomide—brain cancer	0.000135	0.00105	CcSEcCtD
Propafenone—Thrombocytopenia—Etoposide—brain cancer	0.000133	0.00104	CcSEcCtD
Propafenone—Tachycardia—Etoposide—brain cancer	0.000133	0.00103	CcSEcCtD
Propafenone—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000132	0.00754	CbGpPWpGaD
Propafenone—Skin disorder—Etoposide—brain cancer	0.000132	0.00103	CcSEcCtD
Propafenone—Hyperhidrosis—Etoposide—brain cancer	0.000132	0.00102	CcSEcCtD
Propafenone—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000131	0.00744	CbGpPWpGaD
Propafenone—Anorexia—Etoposide—brain cancer	0.00013	0.00101	CcSEcCtD
Propafenone—Hypersensitivity—Carmustine—brain cancer	0.00013	0.00101	CcSEcCtD
Propafenone—Nausea—Hydroxyurea—brain cancer	0.000129	0.00101	CcSEcCtD
Propafenone—Hypotension—Etoposide—brain cancer	0.000127	0.000989	CcSEcCtD
Propafenone—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000127	0.00721	CbGpPWpGaD
Propafenone—Asthenia—Carmustine—brain cancer	0.000126	0.000982	CcSEcCtD
Propafenone—Hypersensitivity—Temozolomide—brain cancer	0.000125	0.000974	CcSEcCtD
Propafenone—Paraesthesia—Etoposide—brain cancer	0.000122	0.00095	CcSEcCtD
Propafenone—Asthenia—Temozolomide—brain cancer	0.000122	0.000949	CcSEcCtD
Propafenone—Dyspnoea—Etoposide—brain cancer	0.000121	0.000943	CcSEcCtD
Propafenone—Somnolence—Etoposide—brain cancer	0.000121	0.00094	CcSEcCtD
Propafenone—Diarrhoea—Carmustine—brain cancer	0.00012	0.000936	CcSEcCtD
Propafenone—Pruritus—Temozolomide—brain cancer	0.00012	0.000935	CcSEcCtD
Propafenone—Decreased appetite—Etoposide—brain cancer	0.000118	0.00092	CcSEcCtD
Propafenone—Gastrointestinal disorder—Etoposide—brain cancer	0.000118	0.000913	CcSEcCtD
Propafenone—Fatigue—Etoposide—brain cancer	0.000117	0.000912	CcSEcCtD
Propafenone—Dizziness—Carmustine—brain cancer	0.000116	0.000905	CcSEcCtD
Propafenone—Constipation—Etoposide—brain cancer	0.000116	0.000905	CcSEcCtD
Propafenone—Pain—Etoposide—brain cancer	0.000116	0.000905	CcSEcCtD
Propafenone—Diarrhoea—Temozolomide—brain cancer	0.000116	0.000905	CcSEcCtD
Propafenone—Dizziness—Temozolomide—brain cancer	0.000113	0.000874	CcSEcCtD
Propafenone—Feeling abnormal—Etoposide—brain cancer	0.000112	0.000872	CcSEcCtD
Propafenone—Vomiting—Carmustine—brain cancer	0.000112	0.00087	CcSEcCtD
Propafenone—Gastrointestinal pain—Etoposide—brain cancer	0.000111	0.000865	CcSEcCtD
Propafenone—Rash—Carmustine—brain cancer	0.000111	0.000863	CcSEcCtD
Propafenone—Dermatitis—Carmustine—brain cancer	0.000111	0.000862	CcSEcCtD
Propafenone—Headache—Carmustine—brain cancer	0.00011	0.000857	CcSEcCtD
Propafenone—Vomiting—Temozolomide—brain cancer	0.000108	0.000841	CcSEcCtD
Propafenone—Urticaria—Etoposide—brain cancer	0.000108	0.00084	CcSEcCtD
Propafenone—SCN5A—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000108	0.00615	CbGpPWpGaD
Propafenone—Body temperature increased—Etoposide—brain cancer	0.000108	0.000836	CcSEcCtD
Propafenone—Abdominal pain—Etoposide—brain cancer	0.000108	0.000836	CcSEcCtD
Propafenone—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000107	0.00611	CbGpPWpGaD
Propafenone—Rash—Temozolomide—brain cancer	0.000107	0.000834	CcSEcCtD
Propafenone—Dermatitis—Temozolomide—brain cancer	0.000107	0.000833	CcSEcCtD
Propafenone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—SKP2—brain cancer	0.000107	0.00608	CbGpPWpGaD
Propafenone—Headache—Temozolomide—brain cancer	0.000107	0.000828	CcSEcCtD
Propafenone—KCNH2—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000105	0.00596	CbGpPWpGaD
Propafenone—Nausea—Carmustine—brain cancer	0.000105	0.000813	CcSEcCtD
Propafenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000102	0.00582	CbGpPWpGaD
Propafenone—Nausea—Temozolomide—brain cancer	0.000101	0.000785	CcSEcCtD
Propafenone—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000101	0.00574	CbGpPWpGaD
Propafenone—Hypersensitivity—Etoposide—brain cancer	0.0001	0.000779	CcSEcCtD
Propafenone—Asthenia—Etoposide—brain cancer	9.77e-05	0.000759	CcSEcCtD
Propafenone—Pruritus—Etoposide—brain cancer	9.63e-05	0.000748	CcSEcCtD
Propafenone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—brain cancer	9.52e-05	0.00542	CbGpPWpGaD
Propafenone—Diarrhoea—Etoposide—brain cancer	9.32e-05	0.000724	CcSEcCtD
Propafenone—Dizziness—Etoposide—brain cancer	9.01e-05	0.0007	CcSEcCtD
Propafenone—CYP3A4—Irinotecan Pathway—APC—brain cancer	8.68e-05	0.00494	CbGpPWpGaD
Propafenone—Vomiting—Etoposide—brain cancer	8.66e-05	0.000673	CcSEcCtD
Propafenone—Rash—Etoposide—brain cancer	8.59e-05	0.000667	CcSEcCtD
Propafenone—Dermatitis—Etoposide—brain cancer	8.58e-05	0.000666	CcSEcCtD
Propafenone—Headache—Etoposide—brain cancer	8.53e-05	0.000663	CcSEcCtD
Propafenone—SCN5A—SIDS Susceptibility Pathways—HES1—brain cancer	8.39e-05	0.00478	CbGpPWpGaD
Propafenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	8.28e-05	0.00472	CbGpPWpGaD
Propafenone—CYP2C8—Biological oxidations—CYP2C9—brain cancer	8.2e-05	0.00467	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—HES1—brain cancer	8.14e-05	0.00463	CbGpPWpGaD
Propafenone—Nausea—Etoposide—brain cancer	8.09e-05	0.000628	CcSEcCtD
Propafenone—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	8.09e-05	0.0046	CbGpPWpGaD
Propafenone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	7.7e-05	0.00438	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—PTCH2—brain cancer	7.27e-05	0.00414	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—TRPC6—brain cancer	7.26e-05	0.00413	CbGpPWpGaD
Propafenone—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	7.07e-05	0.00402	CbGpPWpGaD
Propafenone—CYP2D6—Biological oxidations—CYP2C9—brain cancer	6.73e-05	0.00383	CbGpPWpGaD
Propafenone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—brain cancer	6.67e-05	0.0038	CbGpPWpGaD
Propafenone—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	6.64e-05	0.00378	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—OR14C36—brain cancer	6.38e-05	0.00363	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—OR4C12—brain cancer	6.38e-05	0.00363	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	5.88e-05	0.00335	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—OR14C36—brain cancer	5.79e-05	0.0033	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—OR4C12—brain cancer	5.79e-05	0.0033	CbGpPWpGaD
Propafenone—CYP1A2—Biological oxidations—CYP2C9—brain cancer	5.7e-05	0.00325	CbGpPWpGaD
Propafenone—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	5.62e-05	0.0032	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—TRPC6—brain cancer	5.18e-05	0.00295	CbGpPWpGaD
Propafenone—SCN5A—L1CAM interactions—EGFR—brain cancer	4.92e-05	0.0028	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—PDGFRA—brain cancer	4.55e-05	0.00259	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—CYP2C9—brain cancer	4.4e-05	0.00251	CbGpPWpGaD
Propafenone—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	4.34e-05	0.00247	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—CTNNB1—brain cancer	4.21e-05	0.0024	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—CTNNB1—brain cancer	4.08e-05	0.00232	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	3.8e-05	0.00216	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—SHH—brain cancer	3.75e-05	0.00213	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PTCH2—brain cancer	3.73e-05	0.00212	CbGpPWpGaD
Propafenone—SCN5A—SIDS Susceptibility Pathways—VEGFA—brain cancer	3.71e-05	0.00211	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	3.6e-05	0.00205	CbGpPWpGaD
Propafenone—KCNH2—SIDS Susceptibility Pathways—VEGFA—brain cancer	3.59e-05	0.00204	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—PTCH1—brain cancer	3.55e-05	0.00202	CbGpPWpGaD
Propafenone—ADRB1—GPCR ligand binding—SMO—brain cancer	3.55e-05	0.00202	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—OR14C36—brain cancer	3.42e-05	0.00195	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—OR4C12—brain cancer	3.42e-05	0.00195	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	3.39e-05	0.00193	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—HES1—brain cancer	3.34e-05	0.0019	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—ABR—brain cancer	3.22e-05	0.00184	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	3.15e-05	0.00179	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—S100A10—brain cancer	3.15e-05	0.00179	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	3.06e-05	0.00174	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	3.04e-05	0.00173	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—ABR—brain cancer	2.93e-05	0.00167	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—DTX2—brain cancer	2.91e-05	0.00166	CbGpPWpGaD
Propafenone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—brain cancer	2.85e-05	0.00162	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—ERBB2—brain cancer	2.68e-05	0.00153	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—CDK4—brain cancer	2.62e-05	0.00149	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	2.6e-05	0.00148	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	2.49e-05	0.00142	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—IL2—brain cancer	2.48e-05	0.00141	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	2.45e-05	0.00139	CbGpPWpGaD
Propafenone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—brain cancer	2.44e-05	0.00139	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	2.42e-05	0.00138	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	2.39e-05	0.00136	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	2.34e-05	0.00133	CbGpPWpGaD
Propafenone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	2.34e-05	0.00133	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.3e-05	0.00131	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	2.25e-05	0.00128	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTCH2—brain cancer	2.2e-05	0.00126	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.19e-05	0.00125	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	2.14e-05	0.00122	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HES5—brain cancer	2.13e-05	0.00122	CbGpPWpGaD
Propafenone—ABCB1—Allograft Rejection—VEGFA—brain cancer	2.11e-05	0.0012	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—STRADA—brain cancer	2.07e-05	0.00118	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—VEGFA—brain cancer	2.07e-05	0.00118	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—TRPC6—brain cancer	2.04e-05	0.00116	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—RELA—brain cancer	1.93e-05	0.0011	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—SHH—brain cancer	1.92e-05	0.00109	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—ERBB2—brain cancer	1.91e-05	0.00109	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.87e-05	0.00107	CbGpPWpGaD
Propafenone—SCN5A—Axon guidance—EGFR—brain cancer	1.86e-05	0.00106	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—TRPC6—brain cancer	1.85e-05	0.00106	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	1.85e-05	0.00105	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—SMO—brain cancer	1.82e-05	0.00104	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PTCH1—brain cancer	1.82e-05	0.00104	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	1.74e-05	0.000992	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ABR—brain cancer	1.73e-05	0.000985	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—CTNNB1—brain cancer	1.67e-05	0.000953	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GLI2—brain cancer	1.67e-05	0.000951	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	1.6e-05	0.000911	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GLI1—brain cancer	1.57e-05	0.000894	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—VAV1—brain cancer	1.53e-05	0.000871	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SUFU—brain cancer	1.49e-05	0.000848	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—VEGFA—brain cancer	1.47e-05	0.000839	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—STAT3—brain cancer	1.46e-05	0.000831	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—TRPC6—brain cancer	1.45e-05	0.000828	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—GFAP—brain cancer	1.44e-05	0.000818	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP2C9—brain cancer	1.4e-05	0.000798	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—VAV1—brain cancer	1.39e-05	0.000791	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HEY1—brain cancer	1.36e-05	0.000775	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	1.35e-05	0.00077	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—DLL1—brain cancer	1.34e-05	0.00076	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—EGFR—brain cancer	1.33e-05	0.000755	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP2C9—brain cancer	1.22e-05	0.000695	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	1.19e-05	0.00068	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—BSG—brain cancer	1.19e-05	0.000679	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	1.18e-05	0.000674	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP2C9—brain cancer	1.15e-05	0.000655	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SHH—brain cancer	1.14e-05	0.000647	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TRPC6—brain cancer	1.09e-05	0.000623	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTCH1—brain cancer	1.08e-05	0.000613	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SMO—brain cancer	1.08e-05	0.000613	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	1.04e-05	0.000593	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—BSG—brain cancer	1.04e-05	0.000591	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—IDH1—brain cancer	1.03e-05	0.000584	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—BSG—brain cancer	9.79e-06	0.000557	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP2C9—brain cancer	9.75e-06	0.000555	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PIK3CG—brain cancer	9.71e-06	0.000553	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—BSG—brain cancer	9.7e-06	0.000552	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	9.58e-06	0.000546	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	9.37e-06	0.000534	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—IDH1—brain cancer	8.93e-06	0.000508	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CG—brain cancer	8.82e-06	0.000502	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—NOTCH2—brain cancer	8.61e-06	0.00049	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—IDH1—brain cancer	8.42e-06	0.000479	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.35e-06	0.000475	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—IDH1—brain cancer	8.34e-06	0.000475	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—BSG—brain cancer	8.29e-06	0.000472	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VAV1—brain cancer	8.2e-06	0.000467	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ENO2—brain cancer	8.1e-06	0.000461	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	7.87e-06	0.000448	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP2C9—brain cancer	7.53e-06	0.000428	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—IDH1—brain cancer	7.13e-06	0.000406	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ENO2—brain cancer	7.06e-06	0.000402	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HES1—brain cancer	7.06e-06	0.000402	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—IL2—brain cancer	6.83e-06	0.000389	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.79e-06	0.000387	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PDGFRA—brain cancer	6.72e-06	0.000383	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ENO2—brain cancer	6.65e-06	0.000379	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ENO2—brain cancer	6.6e-06	0.000375	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—SPP1—brain cancer	6.52e-06	0.000371	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—BSG—brain cancer	6.4e-06	0.000364	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL2—brain cancer	6.21e-06	0.000353	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IRS2—brain cancer	5.9e-06	0.000336	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.81e-06	0.000331	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ENO2—brain cancer	5.64e-06	0.000321	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—IDH1—brain cancer	5.5e-06	0.000313	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CG—brain cancer	5.21e-06	0.000297	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APC—brain cancer	5.21e-06	0.000297	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—EGFR—brain cancer	4.75e-06	0.00027	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ENO2—brain cancer	4.35e-06	0.000248	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RELA—brain cancer	4.07e-06	0.000232	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ERBB2—brain cancer	4.04e-06	0.00023	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CG—brain cancer	3.72e-06	0.000212	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL2—brain cancer	3.67e-06	0.000209	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCND1—brain cancer	3.57e-06	0.000203	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CTNNB1—brain cancer	3.54e-06	0.000201	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CG—brain cancer	3.24e-06	0.000184	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VEGFA—brain cancer	3.12e-06	0.000177	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—STAT3—brain cancer	3.08e-06	0.000176	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CG—brain cancer	3.05e-06	0.000174	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CG—brain cancer	3.03e-06	0.000172	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MYC—brain cancer	2.87e-06	0.000163	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EGFR—brain cancer	2.8e-06	0.00016	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CG—brain cancer	2.59e-06	0.000147	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TP53—brain cancer	2.35e-06	0.000134	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CG—brain cancer	2e-06	0.000114	CbGpPWpGaD
